Revolution Medicines Inc
F:42Z
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Revolution Medicines Inc
F:42Z
|
US |
|
Alstom SA
F:AOMU
|
FR |
|
Chalice Mining Ltd
ASX:CHN
|
AU |
|
L
|
Lululemon Athletica Inc
LSE:0JVT
|
CA |
|
N
|
National Bank of Canada
OTC:NTIOF
|
CA |
|
G
|
Gentili Mosconi SpA
MIL:GM
|
IT |
|
HeidelbergCement AG
XETRA:HEI
|
DE |
|
C
|
ConvaTec Group PLC
OTC:CNVVY
|
UK |
|
Ceconomy AG
XETRA:CEC
|
DE |
|
Gartner Inc
NYSE:IT
|
US |
Wall St Price Targets
42Z Price Targets Summary
Revolution Medicines Inc
According to Wall Street analysts, the average 1-year price target for
42Z is 46.18 EUR with a low forecast of 36.1 EUR and a high forecast of 65.37 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 42Z's stock price target?
Price Target
46.18
EUR
According to Wall Street analysts, the average 1-year price target for
42Z is 46.18 EUR with a low forecast of 36.1 EUR and a high forecast of 65.37 EUR.